Severe pulmonary hypertension in chronic obstructive pulmonary disease – From clinical perspective to histological evidence
2024

Severe Pulmonary Hypertension in COPD

Sample size: 139 publication 10 minutes Evidence: moderate

Author Information

Author(s): Katarina Zeder, Teresa Sassmann, Vasile Foris, Philipp Douschan, Horst Olschewski, Gabor Kovacs

Primary Institution: Medical University of Graz, Austria

Hypothesis

What is the clinical and histopathological evidence of severe pulmonary hypertension in chronic obstructive pulmonary disease?

Conclusion

Severe pulmonary hypertension in COPD is defined by elevated pulmonary arterial pressure and pulmonary vascular resistance greater than 5 wood units, leading to poor prognosis despite less severe airflow obstruction.

Supporting Evidence

  • Severe pulmonary hypertension is associated with poor prognosis in COPD patients.
  • Pulmonary vascular resistance is a better predictor of mortality than mean pulmonary arterial pressure.
  • Histological analysis shows significant remodeling of small pulmonary arterioles in COPD patients with severe PH.

Takeaway

This study looks at how severe lung pressure affects people with breathing problems, showing that even if their lungs don't seem too bad, they can still be very sick.

Methodology

The study involved analyzing clinical data and histological samples from COPD patients with severe pulmonary hypertension.

Potential Biases

Potential bias in patient selection and retrospective analysis.

Limitations

The study lacks sufficiently powered prospective randomized controlled trials to confirm treatment benefits.

Participant Demographics

139 COPD patients, 55% male, median age 68 years.

Statistical Information

P-Value

p=0.007

Confidence Interval

[1.58–4.27]

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1016/j.ijcchd.2024.100519

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication